KamilDetynieckiMD

Neurology • Miami, FL

Epilepsy

Associate Professor of Neurology, University of Miami Miller School of Medicine

Join to view full profile

Dr. Detyniecki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Detyniecki's full profile

Already have an account?

Office
1120 NW 14th St
Miami, FL 33136
Phone+1 305-243-4658

Education & Training

Yale-New Haven Medical CenterFellowship, Epilepsy, 2008 - 2010
Drexel University College of Medicine/Hahnemann University HospitalResidency, Neurology, 2005 - 2008
St Agnes HealthCareInternship, Internal Medicine, 2004 - 2005
Vogtland Klinikum PlauenIntern, General Surgery, 2003 - 2003
St. Elizabeth Teaching HospitalIntern, Medicine, 2001 - 2002
Medical University of WarsawClass of 2001

Certifications & Licensure

FL State Medical License 2018 - 2025
CT State Medical License 2010 - 2019
PA State Medical License 2005 - 2010
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Epilepsy

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) Start of enrollment: 2010 Dec 01
Completed
Phase 4
Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters Start of enrollment: 2011 Jun 01
Terminated
Phase 3
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters Start of enrollment: 2012 Jul 01
Terminated
Phase 3
Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU Start of enrollment: 2013 Nov 01
Completed
Phase 3
The Human Epilepsy Project Start of enrollment: 2012 Jul 01
Completed
A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures Start of enrollment: 2020 Jan 27
Active, not recruiting
Phase 2
Roles: Contact
Study of EQU-001 for Uncontrolled Focal Onset Seizures Start of enrollment: 2022 Dec 27
Terminated
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Short-Term Impact of Seizures and Mitigation Opportunities.
Tracy Glauser, Danielle A Becker, Lucretia Long, Kamil Detyniecki, Patricia Penovich
Current Neurology and Neuroscience Reports. 2024-08-01
4 citations
Return to full baseline functionality after repeated intermittent use of midazolam nasal spray in patients with seizure clusters: Post hoc analysis of an open-label ex...
Kamil Detyniecki, Marcus Brunnert, Rita Campos, Svetlana Dimova, James W Wheless
Epilepsy & Behavior. 2023-10-28
1 citations
A De Novo HECW2 Variant in a Patient with Acetazolamide-Responsive Episodic Ataxia.
Leticia Maria Tedesco Silva, Sonali Sharma, Isabelle Schrauwen, Jason Margolesky, Kamil Detyniecki
Cerebellum. 2023-10-01

Journal Articles

Prevalence and Predictors of Seizure Clusters: A Prospective Observational Study of Adult Patients with Epilepsy
Kamil Detyniecki, Lawrence J Hirsch, Epilepsy & Behavior

Grant Support

PET imaging of SV2A receptors in Epilepsy patientsSwebilius FoundationPresent

Professional Memberships

American Academy of Neurology - AAN
Member
American Epilepsy Society - AES
Member

Other Languages

Spanish, Polish, Portuguese, German, French